• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五氟利多:一种长效口服抗精神病药物。

Penfluridol: a long acting oral antipsychotic drug.

作者信息

Claghorn J L, Mathew R J, Mirabi M

出版信息

J Clin Psychiatry. 1979 Feb;40(2):107-9.

PMID:368045
Abstract

Penfluridol is a diphenylbutylpiperdine derivative with a half-life of sixty-six (66) hours. The present study was designed to determine its efficacy for the maintenance of schizophrenia. In a 52 week double-blind study, once weekly doses of penfluridol were compared with once daily doses of chlorpromazine in 56 schizophrenic patients receiving maintenance treatment on an outpatient basis. Both drugs were similar in their clinical effectiveness; no major side effects occurred with either drug.

摘要

五氟利多是一种二苯基丁基哌啶衍生物,半衰期为66小时。本研究旨在确定其对维持治疗精神分裂症的疗效。在一项为期52周的双盲研究中,将56例接受门诊维持治疗的精神分裂症患者每周一次剂量的五氟利多与每日一次剂量的氯丙嗪进行比较。两种药物的临床疗效相似;两种药物均未出现重大副作用。

相似文献

1
Penfluridol: a long acting oral antipsychotic drug.五氟利多:一种长效口服抗精神病药物。
J Clin Psychiatry. 1979 Feb;40(2):107-9.
2
A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.五氟利多与癸酸氟奋乃静治疗门诊精神分裂症患者的长期对照试验。
J Clin Psychiatry. 1978 Apr;39(4):375-9.
3
A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients.慢性精神分裂症门诊患者中五氟利多与三氟拉嗪的十二个月比较。
J Clin Psychiatry. 1978 Jun;39(6):582-3, 686-8.
4
Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.五氟利多与三氟拉嗪治疗慢性精神分裂症的短期对照研究
Indian J Physiol Pharmacol. 1988 Oct-Dec;32(4):293-8.
5
[Penfluridol. Results of a year-long clinical trial].
Int Pharmacopsychiatry. 1978;13(1):1-15.
6
The treatment of schizophrenia with long-acting oral neuroleptics: a six-month double-blind investigation of penfluridol versus trifluoperazine.
Psychopharmacol Bull. 1977 Jul;13(3):26-7.
7
Penfluridol in the maintenance treatment of schizophrenic patients newly discharged from a brief therapy unit.五氟利多在短期治疗病房新出院精神分裂症患者维持治疗中的应用
J Clin Pharmacol. 1977 Feb-Mar;17(2-3):162-7. doi: 10.1002/j.1552-4604.1977.tb04602.x.
8
Study of penfluridol and chlorpromazine in the treatment of chronic schizophrenia.五氟利多与氯丙嗪治疗慢性精神分裂症的研究。
J Clin Pharmacol. 1982 May-Jun;22(5-6):236-42. doi: 10.1002/j.1552-4604.1982.tb02667.x.
9
[Application of NOSIE in the study of neuroleptic treatment].
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1987 Dec;20(6):325-7.
10
A one-year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple-episode schizophrenics.
Psychopharmacol Bull. 1977 Jul;13(3):27-9.

引用本文的文献

1
Case Report: Long-Acting Oral Cariprazine.病例报告:长效口服卡立普嗪
Front Psychiatry. 2022 Apr 27;13:876003. doi: 10.3389/fpsyt.2022.876003. eCollection 2022.
2
Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?每周监督口服抗精神病药物治疗:长效注射的替代方案?
CNS Drugs. 2022 Apr;36(4):315-325. doi: 10.1007/s40263-022-00906-4. Epub 2022 Feb 28.
3
Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein.用于探索严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白成药潜力的监督式分子动力学
J Comput Aided Mol Des. 2021 Feb;35(2):195-207. doi: 10.1007/s10822-020-00356-4. Epub 2020 Oct 26.
4
Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.作为具有降低中枢神经系统活性的化疗药物的五氟利多类似物。
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3652-3657. doi: 10.1016/j.bmcl.2018.10.036. Epub 2018 Oct 24.
5
Chlorpromazine versus penfluridol for schizophrenia.氯丙嗪与五氟利多治疗精神分裂症的比较。
Cochrane Database Syst Rev. 2017 Sep 23;9(9):CD011831. doi: 10.1002/14651858.CD011831.pub2.
6
Penfluridol for schizophrenia.五氟利多治疗精神分裂症。
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD002923. doi: 10.1002/14651858.CD002923.pub2.